- Repair
- Annuloplasty
- Valvuloplasty
- Transcatheter Mitral Valve Repair (TMVR)
- Others
- Replacement
- Surgical Valve
- Mechanical Heart Valve
- Tissue Heart Valve
- Transcatheter Aortic Valve Replacement (TAVR)
Structural Heart Devices Market was valued at USD 7,198.2 million in 2023 and is poised to grow at a CAGR of 9.7 %. The market is driven by factors such as the rising prevalence of cardiovascular diseases, minimally invasive procedures, favorable reimbursement scenarios, and growing awareness. Globally, heart disease is a major killer, and the incidence of these conditions is expected to rise due to an aging population and increasing risk factors like obesity and diabetes. This creates a larger patient pool needing treatment. Structural heart devices enable minimally invasive procedures like transcatheter aortic valve replacement (TAVR), which offer quicker recovery times and less patient discomfort compared to open-heart surgery. This shift towards minimally invasive treatments is a major growth factor.
Government and insurance policies that reimburse hospitals and doctors for structural heart procedures incentivize their use, making them more accessible to patients. Increased public awareness about structural heart diseases and treatment options leads to earlier diagnosis and a willingness to undergo these procedures. Despite the growth of the market, the constraints that hinder the market growth are the high cost of devices, uncertainties of reimbursement, and long-term durability concerns. These devices can be expensive, limiting access in regions with restricted healthcare budgets. Changes in reimbursement policies or coverage restrictions could dampen market growth. While newer devices show promise, the long-term durability of some structural heart devices compared to traditional surgical valves is still being evaluated.
Structural Heart Devices Market Key Developments:
- In February 2022, Genesis MedTech Group completed the acquisition of JC Medical (JCM).
- In Nov 2023, Medtronic recently launched the Penditure™ Left Atrial Appendage (LAA) Exclusion Systemin the United States.
- In Nov 2023, J&J Medtech acquired Laminar, Inc., an innovative investigational device designed for Left Atrial Appendage Elimination (LAAX).
Structural Heart Devices Market Summary
Study Period
2024 - 2030
Base Year
2023
CAGR
9.7%
Largest Market
Asia Pacific
Fastest Growing Market
Asia Pacific
Structural Heart Devices Market Dynamics
The development of new and improved devices with better efficacy, and durability, through advanced technology, and ease of use will create opportunities for market expansion. Increasing healthcare spending in developing countries creates new markets for structural heart devices. A shift towards preventative care and early intervention for heart diseases could lead to a rise in demand for these devices. The trend towards minimally invasive procedures is likely to continue, with further development of devices and techniques for mitral and tricuspid valve repair. Manufacturers are focusing on developing devices that improve patient outcomes, such as reducing complications and improving long-term survival rates. The use of data analytics to track patient outcomes and improve device design is becoming increasingly important.
Asia-Pacific Got Significant Share of
Structural Heart Devices Market Regional Analysis
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Asia Pacific (APAC) region is expected to be the fastest-growing market, with China, India, Japan, and South Korea leading the charge. Factors like growing economies, rising life expectancy, investments in healthcare infrastructure, and potentially lower device costs are propelling this growth. North America region is a well-established market with a high adoption rate of structural heart devices. The US dominates this region, with a large patient pool and established reimbursement practices. Europe represents a mature market with significant players. However, stringent regulatory processes can sometimes slow down the market adoption of new devices. The Rest of the World region holds potential for future growth, with developing countries increasing their focus on improving healthcare infrastructure and affordability of these devices.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
Structural Heart Devices Market Segmentation
By Procedure
By position
- Aorta
- Mitral
- Pulmonary valve
- Tricuspid valve
By Product
- Heart Valve Devices
- Occluders Delivery Systems
- Annuloplasty Rings
- Others
Frequently Asked Questions
The Structural Heart Devices Market was valued at USD 7,198.2 million in 2023 and growing at a CAGR of 9.7 %.
The market is driven by factors such as the rising prevalence of cardiovascular diseases, minimally invasive procedures, favorable reimbursement scenarios, and growing awareness.
Edwards Lifesciences Corporation , Medtronic plc , Abbott, Boston Scientific Corporation, LivaNova plc , CryoLife, Inc., Micro Interventional Devices, Inc, Bralie Biomédica, Lepu Medical Technology (Beijing) Co. Ltd., TTK Healthcare Limited , and Cook Group Incorporated
North America is the dominant in the Structural Heart Devices Market.
| 1.Executive Summary |
| 2.Global Structural Heart Devices Market Introduction |
| 2.1.Global Structural Heart Devices Market - Taxonomy |
| 2.2.Global Structural Heart Devices Market - Definitions |
| 2.2.1. Procedure |
| 2.2.2. Position |
| 2.2.3.Product |
| 2.2.4. Region |
| 3.Global Structural Heart Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Structural Heart Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Structural Heart Devices Market By Procedure, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Repair |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Replacement |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Structural Heart Devices Market By Position, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Aorta |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Mitral |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Pulmonary valve |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Tricuspid valve |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Structural Heart Devices Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Heart Valve Devices |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Occluders Delivery Systems |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Annuloplasty Rings |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Structural Heart Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Structural Heart Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Repair |
| 9.1.2.Replacement |
| 9.2. Position Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Aorta |
| 9.2.2.Mitral |
| 9.2.3.Pulmonary valve |
| 9.2.4.Tricuspid valve |
| 9.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Heart Valve Devices |
| 9.3.2.Occluders Delivery Systems |
| 9.3.3.Annuloplasty Rings |
| 9.3.4.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Structural Heart Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Procedure Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Repair |
| 10.1.2.Replacement |
| 10.2. Position Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Aorta |
| 10.2.2.Mitral |
| 10.2.3.Pulmonary valve |
| 10.2.4.Tricuspid valve |
| 10.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Heart Valve Devices |
| 10.3.2.Occluders Delivery Systems |
| 10.3.3.Annuloplasty Rings |
| 10.3.4.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Structural Heart Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Procedure Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Repair |
| 11.1.2.Replacement |
| 11.2. Position Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Aorta |
| 11.2.2.Mitral |
| 11.2.3.Pulmonary valve |
| 11.2.4.Tricuspid valve |
| 11.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Heart Valve Devices |
| 11.3.2.Occluders Delivery Systems |
| 11.3.3.Annuloplasty Rings |
| 11.3.4.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Structural Heart Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Procedure Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Repair |
| 12.1.2.Replacement |
| 12.2. Position Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Aorta |
| 12.2.2.Mitral |
| 12.2.3.Pulmonary valve |
| 12.2.4.Tricuspid valve |
| 12.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Heart Valve Devices |
| 12.3.2.Occluders Delivery Systems |
| 12.3.3.Annuloplasty Rings |
| 12.3.4.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Structural Heart Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Procedure Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Repair |
| 13.1.2.Replacement |
| 13.2. Position Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Aorta |
| 13.2.2.Mitral |
| 13.2.3.Pulmonary valve |
| 13.2.4.Tricuspid valve |
| 13.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Heart Valve Devices |
| 13.3.2.Occluders Delivery Systems |
| 13.3.3.Annuloplasty Rings |
| 13.3.4.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Edwards Lifesciences Corporation |
| 14.2.2.Medtronic plc |
| 14.2.3.Abbott |
| 14.2.4.Boston Scientific Corporation |
| 14.2.5.LivaNova plc |
| 14.2.6.CryoLife, Inc. |
| 14.2.7.Micro Interventional Devices, Inc |
| 14.2.8.Bralie Biomédica |
| 14.2.9.Lepu Medical Technology (Beijing) Co. Ltd. |
| 14.2.10.TTK Healthcare Limited |
| 14.2.11.Cook Group Incorporated |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Edwards Lifesciences Corporation
- Medtronic plc
- Abbott
- Boston Scientific Corporation
- LivaNova plc
- CryoLife, Inc.
- Micro Interventional Devices, Inc
- Bralie Biomédica
- Lepu Medical Technology (Beijing) Co. Ltd.
- TTK Healthcare Limited
- Cook Group Incorporated